Weisberg Edith, Fraser Ian
Research Division, FPA Health, New South Wales, Australia.
Aust Fam Physician. 2005 Aug;34(8):694-6.
To describe Australian women's experiences and acceptability of etonogestrel releasing subdermal contraceptive implant (Implanon).
Six hundred and fifty-one women were recruited at the time of implant insertion and asked to complete a self administered questionnaire immediately after insertion and at 3, 6 and 12 months after insertion.
Four hundred and seventy-five women aged 15-50 years responded at least once. Forty-one women had the device removed before 3 months, 48 between 3-6 months, and 75 between 6-12 months. Removal was mainly because of side effects, especially frequent or prolonged vaginal bleeding which was the reason for significantly more women to have their device removed (18% at 3, and 37% at 12 months) compared to women with no or infrequent bleeding. Most rated the implant as "good to excellent", including 56/164 of those who discontinued its use in the first 12 months.
Implanon is acceptable contraception to women in all reproductive age groups. Change in bleeding patterns was the main cause for dissatisfaction. Providing women with detailed information before insertion of the implant is important.
描述澳大利亚女性使用依托孕烯皮下埋植避孕剂(依伴侬)的经历及可接受性。
651名女性在植入该避孕剂时被招募,并被要求在植入后即刻、植入后3个月、6个月和12个月时完成一份自填式问卷。
475名年龄在15至50岁之间的女性至少回复了一次。41名女性在3个月前取出了该装置,48名在3至6个月之间取出,75名在6至12个月之间取出。取出的主要原因是副作用,尤其是频繁或长期的阴道出血,与无出血或出血不频繁的女性相比,因该原因取出装置的女性明显更多(3个月时为18%,12个月时为37%)。大多数人对该植入剂的评价为“良好至优秀”,包括在最初12个月内停止使用的164人中的56人。
依伴侬对所有育龄期女性来说都是可接受的避孕方法。出血模式的改变是不满的主要原因。在植入该避孕剂前为女性提供详细信息很重要。